Ceramic systems for long‐term delivery of chemicals and biologicals
- 1 December 1988
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 22 (12) , 1245-1266
- https://doi.org/10.1002/jbm.820221212
Abstract
Evaluation of devices, drugs, and drug delivery systems have been investigated by both in vitro and in vivo procedures. Ceramic drug delivery systems can be used to evaluate chemicals and biologicals by both in vitro and in vivo procedures. The system can also reduce handling of the animals and facilitate long-term evaluations before conducting clinical trials. To date, ceramic systems have been used to deliver aldosterone, androstanedione, beta-lactoglobulin, bovine serum albumin, chymotrypsin, danazol, difluoromeythylornithine, dihydrotestosterone, estradiol, gamma globulin, gonadotrophic releasing hormone, gossypol, growth hormone, insulin, methylene blue, pepsin, progesterone, and testosterone. The data obtained suggest that ceramic delivery systems can be used in the near future to treat diseases requiring long-term chronic drug therapy as well as disorders caused by deficiency of certain hormones.This publication has 6 references indexed in Scilit:
- FRACTURING DIALYSIS OSTEODYSTROPHY AND DIALYSIS ENCEPHALOPATHY: An Epidemiological SurveyPublished by Elsevier ,1979
- Dialysis Encephalopathy SyndromeAnnual Review of Medicine, 1978
- The Dialysis Encephalopathy SyndromeNew England Journal of Medicine, 1976
- Hypercalcemia and Malignant DiseaseMedical Clinics of North America, 1975
- Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degenerationPhysiology & Behavior, 1973
- Potential of ceramic materials as permanently implantable skeletal prosthesesJournal of Biomedical Materials Research, 1970